The bill amends the Public Health Code by adding Section 21525, which mandates that hospitals conducting drug screens for diagnosing drug overdoses must include tests for "qualified substances." The results of these tests must be reported to the Department of Health and Human Services (DHHS) in a specified format, ensuring that patient identifiers are not included, thus maintaining confidentiality. The information collected will be used by the DHHS to analyze and publish reports on trends and risk factors related to qualified substances.

Additionally, the bill requires the DHHS, in consultation with the relevant department, to establish and periodically review a list of qualified substances for drug screens within 180 days of the bill's enactment. The definitions provided in the bill clarify that a "drug screen" refers to a chemical analysis for multiple substances, while "qualified substances" are those identified by the department in the established rules.

Statutes affected:
House Introduced Bill: 333.1101, 333.25211